Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Meares

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptakeD A Goodwin, C F Meares, M McTigue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1985
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouseD A Goodwin, C F Meares, M J McCall, et al.
The Journal of Biological Chemistry|January 16, 1999
Organization of open complexes at Escherichia coli promoters. Location of promoter DNA sites close to region 2.5 of the sigma70 subunit of RNA polymeraseJ A Bown, J T Owens, C F Meares, et al.
Cancer Research|February 15, 1992
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapyC Kosmas, D Snook, C S Gooden, et al.
Oncology Reports|April 4, 1998
Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysisS Nicholson, C S Gooden, V Hird, et al.
Cancer|February 1, 1994
A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugatesD L Kukis, H Diril, D P Greiner, et al.
European Journal of Nuclear Medicine|January 1, 1986
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in miceM K Haseman, D A Goodwin, C F Meares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1991
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62C J Mathias, M J Welch, M A Green, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Metabolite production in patients with lymphoma after radiometal-labeled antibody administrationG L DeNardo, S J DeNardo, D L Kukis, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancerS J DeNardo, S V Deshpande, M K Moi, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1992
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptakeD A Goodwin, C F Meares, M McTigue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1985
Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouseD A Goodwin, C F Meares, M J McCall, et al.
The Journal of Biological Chemistry|January 16, 1999
Organization of open complexes at Escherichia coli promoters. Location of promoter DNA sites close to region 2.5 of the sigma70 subunit of RNA polymeraseJ A Bown, J T Owens, C F Meares, et al.
Cancer Research|February 15, 1992
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapyC Kosmas, D Snook, C S Gooden, et al.
Oncology Reports|April 4, 1998
Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysisS Nicholson, C S Gooden, V Hird, et al.
Cancer|February 1, 1994
A comparative study of copper-67 radiolabeling and kinetic stabilities of antibody-macrocycle chelate conjugatesD L Kukis, H Diril, D P Greiner, et al.
European Journal of Nuclear Medicine|January 1, 1986
Metabolizable 111In chelate conjugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in miceM K Haseman, D A Goodwin, C F Meares, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1991
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62C J Mathias, M J Welch, M A Green, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Metabolite production in patients with lymphoma after radiometal-labeled antibody administrationG L DeNardo, S J DeNardo, D L Kukis, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancerS J DeNardo, S V Deshpande, M K Moi, et al.
Pageof 15